BridgeMD
New treatment option for Amnesia
Official title How do Patients With Amnesia Acquire New Knowledge?
ClinicalTrials.gov ID: NCT07191197
What this study is testing
- What it's testing
- THE STUDY AIMS to constitute the largest group of patients with major memory impairment resulting from various etiology and specific lesions of the medial temporal lobe (MTL) and use a combined psychometric and neuroimaging approach to study the factors allowing these patients to successfully learn new semantic information.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Patients aged between 18 and 70 years
- Living in France since less than 20 years, being able to understand the French language, and have basic cultural knowledge as evaluated in classical...
- Written agreement to participate in the study
- Intellectual capacities compatible with the cognitive tasks and signing of consent
- Affiliation to the French social security system
You likely can't join if
- people under the age of 18 or over 70
- Contraindications for MRI (examples: wearers of a pacemaker or cardiac defibrillator, implanted equipment activated by an electrical, magnetic or...
- Refusal to be informed of an anomaly detected during the MRI
See the full eligibility criteria
- Patients aged between 18 and 70 years
- Living in France since less than 20 years, being able to understand the French language, and have basic cultural knowledge as evaluated in classical clinical consultation
- Written agreement to participate in the study
- Intellectual capacities compatible with the cognitive tasks and signing of consent
- Affiliation to the French social security system
- For patients: bilateral brain lesion of the medial temporal lobe or the extended hippocampal system
- people under the age of 18 or over 70
- Contraindications for MRI (examples: wearers of a pacemaker or cardiac defibrillator, implanted equipment activated by an electrical, magnetic or mechanical system, wearers of haemostatic clips for intracerebral...
- Refusal to be informed of an anomaly detected during the MRI
The study team makes the final eligibility decision.
Where it's taking place
- Caen, France
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Caen, France; Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.